Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

earnings per share growth forecast for the next five years is 35.00 percent. Alkermes' trailing-twelve-month gross margin is 74.70 percent.

EPS growth forecast for the next five years is 33.00 percent. Flamel Technologies' trailing-twelve-month revenue is $42.90 million.

EPS growth forecast for the next five years is 15.00 percent. Delcath Systems' trailing-twelve-month revenue is $1.40 million.

earnings per share growth forecast for the next five years is 5.00 percent. Petmed Express' PEG ratio is 3.52.